Keywords: پلاکت پلاسمای ضعیف; CMC; Chemistry, Manufacturing and Controls; CoG; cost of goods; CRO; Contract Research Organization; DTT; dithiothreitol; DSP; downstream process; Fd; heavy chain fragment; GP; glycoprotein; HRP; horseradish peroxidase; IEF; Isoelectrofocusing; Mr; relati
مقالات ISI پلاکت پلاسمای ضعیف (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پلاکت پلاسمای ضعیف; Cyclooxygenase; Tectorigenin; Isoflavones; Platelets; AA; arachidonic acid; ASA; acetylsalicylic acid; COX-1; cyclooxygenase-1; EDTA; ethylendiamintetraacetic acid; PRP; platelet rich plasma; PPP; platelet poor plasma; TXA2; thromboxane A2;
Keywords: پلاکت پلاسمای ضعیف; ADM; adrenomedullin; ANA; anagrelide; ANASA; patients on anagrelide and aspirin; ASA; aspirin; AV; annexin V; CTR; control group; EC; endothelia cell; EDRF; endothelium derived relaxing factor; EMP; endothelial derived microparticles; ET; essential thromb
Keywords: پلاکت پلاسمای ضعیف; CDTs; clot dissolving times; Chol; cholesterol; CholS; cholesterol sulfate; DCP; dicetyl phosphate; DMPC; dimyristoyl phosphatidylcholine; DOPC; dioleoyl phosphatidylcholine; DOPE; dioleoyl phosphatidylethanolamine; DPPC; dipalmitoyl phosphatidylcholine;
Keywords: پلاکت پلاسمای ضعیف; PT; prothrombin time; APTT; activated partial thromboplastin time; CAT; calibrated automated thrombography; PL; phospholipid; TCal; thrombin calibrator; PPP; platelet poor plasma; TG; thrombin generation; ETP; endogenous thrombin potential; CV; coefficien
Keywords: پلاکت پلاسمای ضعیف; AA; arachidonic acid; ADP; adenosine diphosphate; PA; platelet aggregation; CV; cardiovascular; CVD; cardiovascular disease; CAM; complementary and alternative medicine; PRP; platelet rich plasma; PPP; platelet poor plasma; IPA; inhibition of platelet agg
Keywords: پلاکت پلاسمای ضعیف; Complementary therapy; Hemorrhage; Echis carinatus venom metalloproteases; Local tissue damage; Myotoxicity; Zinc chelating agents; DTPA; diethylene triamine pentaacetic acid; ECVMPs; Echis carinatus venom metalloproteases; MMPs; matrix metalloproteases;
Keywords: پلاکت پلاسمای ضعیف; ADP; adenosine diphosphate; ANOVA; analysis of variance; APC; allophycocyanin; aPTT; activated partial thromboplastin time; COX-1; cyclooxygenase-1; CVD; cardiovascular disease; C3GE; cyanidin-3-glucoside equivalents; FBC; full blood count; FITC; fluoresc
Keywords: پلاکت پلاسمای ضعیف; TF; tissue factor; APTT; activated partial thromboplastin time; PFP; platelet free plasma; PPP; platelet poor plasma; Coagulation tests; thrombodynamics; pre-analytical variables;
Keywords: پلاکت پلاسمای ضعیف; CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Keywords: پلاکت پلاسمای ضعیف; (AA); arachidonic acid; (ACE); angiotensin converting enzyme; (ADP); adenosine diphosphate; (ARU); aspirin reaction unit; (CABG); coronary artery bypass graft; (CBC); complete blood count; (COX-1); cyclooxygenase-1; (11dhTxB2); 11-dehydro thromboxane B2;
Keywords: پلاکت پلاسمای ضعیف; ACS; acute coronary syndrome; ADP; adenosine diphosphate; ADR; adverse drug reaction; CABG; coronary artery bypass surgery; CI; confidence interval; CV; cardiovascular; CYP; cytochrome p450; HOPR; high on-treatment platelet reactivity; HR; hazard ratio; H
Keywords: پلاکت پلاسمای ضعیف; DPSCs; dental pulp stromal cells; MSC; mesenchymal stromal cells; SHEDs; stromal cells from human exfoliated deciduous; BM-MSCs; bone marrow-derived mesenchymal stromal cells; NTFs; neurotrophic factors; NGF; nerve growth factor; BDNF; brain-derived neuro
Keywords: پلاکت پلاسمای ضعیف; 5-FU; 5-fluorouracil; CRC; curcumin; TCS; thiolated chitosan; FT-IR; Fourier transform infrared spectroscopy; DDA; degree of deacetylation; DLS; dynamic light scattering; PBS; phosphate buffered saline; SEM; scanning electron microscope; FBS; fetal bovine
Keywords: پلاکت پلاسمای ضعیف; Hct; haematocrit level; PLT; platelet count; PRP; platelet rich plasma; PPP; platelet poor plasma; CT; clotting time; CFT; clot formation time; MCF; maximum clot firmness; α; alpha angle; Factors of influence; Haematocrit level; Platelet count; In-vitro;
Keywords: پلاکت پلاسمای ضعیف; AT; antithrombin; AZ; AstraZeneca; CAT; calibrated automated thrombogram; ETP; endogenous thrombin potential; LT; lag time; HTS; high-throughput screening; PPP; platelet poor plasma; PRP; platelet rich plasma; RU; resonance units; SPR; surface plasmon res
Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats
Keywords: پلاکت پلاسمای ضعیف; CAT; calibrated automated test; ETP; endogenous thrombin potential; F; factor; LT; lag time; PD; pharmacodynamics; PH; peak height; PNrP; pooled normal rat plasma; PPP; platelet poor plasma; PT; prothrombin time; TGT; thrombin generation test; TTP; time t
In vitro efficacy of silk sericin microparticles and platelet lysate for intervertebral disk regeneration
Keywords: پلاکت پلاسمای ضعیف; SS; silk sericin; PL; platelet lysate; PPP; platelet poor plasma; PRP; platelet rich plasma; IVD; invertebral disk; FBS; fetal bovine serum; CD; cellular doubling; NP; nucleus pulposus cells; MSC; adipose-derived mesenchymal stem/stromal cells; ROS; radic
Purified polysaccharides of Geoffroea spinosa barks have anticoagulant and antithrombotic activities devoid of hemorrhagic risks
Keywords: پلاکت پلاسمای ضعیف; Polysaccharides; Geoffroea spinosa; Structure; Anticoagulant; Antithrombotic; Antiplatelet; aPTT; activated partial thromboplastin time; PT; prothrombin time; ADP; adenosine diphosphate; TPL; total polysaccharides; BSA; bovine serum albumin; PRP; platelet
Ecotin: Exploring a feasible antithrombotic profile
Keywords: پلاکت پلاسمای ضعیف; Ecotin; Thrombin inhibitor; Factor Xa inhibitor; Ecotin-WT; ecotin wild type; ecotin-RR; ecotin with two mutations at the primary binding site; TF.FVIIa; tissue factor-factor VIIa; PT; prothrombin time; APTT; activated partial thromboplastin time; TT; t
2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro
Keywords: پلاکت پلاسمای ضعیف; THSG; 2,3,5,4'-tetrahydroxystilbene-2-O-β-D glucoside; PRP; platelet rich plasma; PPP; platelet poor plasma; U46619; 9,11-Dideoxy-9a,11a-methanoepoxy prostaglandin F2a; TxA2; thromboxaneA2; ADP; adenosine diphosphate; ATP; adenosine triphosphate; PGE1;
An analysis of endothelial microparticles as a function of cell surface antibodies and centrifugation techniques
Keywords: پلاکت پلاسمای ضعیف; Endothelial microparticles; Imaging flow cytometry; Platelet poor plasma; Atherosclerosis
A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa
Keywords: پلاکت پلاسمای ضعیف; Anticoagulant peptide; Biosensor analysis; Daboia russelii russelii; Factor Xa inhibitor; Protein-protein interaction; Thrombin inhibitor; ALP; alkaline phosphatase; AT-III; antithrombin-III; BLASTP; basic local alignment search tool; CD; circular dichr
Phosphodiesterase from Daboia russelli russelli venom: Purification, partial characterization and inhibition of platelet aggregation
Keywords: پلاکت پلاسمای ضعیف; Phosphodiesterase; Daboia russelli russelli; Snake venom; Platelet aggregation; Enzyme inhibition; ADP; adenosine diphosphate; AMP; adenosine monophosphate; ATP; adenosine triphosphate; AVS; anti-venom serum; BCIP; 5-bromo-4-chloro-3â²-indolyphosphate; b
Plasma and Whole Blood Clot Strength Measured by Thrombelastography in Patients Treated with Clopidogrel during Acute Coronary Syndromes
Keywords: پلاکت پلاسمای ضعیف; CRP; C-reactive protein; NSTEMI; non-ST segment elevation myocardial infarction; LTA; light transmittance aggregometry; ADP; adenosine 5'-diphosphate; TRAP; thrombin receptor activation peptide; ACS; acute coronary syndrome; PPP; platelet poor plasma; P
Hypercoagulability Markers Predict Thrombosis in Single Ventricle Neonates Undergoing Cardiac Surgery
Keywords: پلاکت پلاسمای ضعیف; 21; ATIII; antithrombin III; CI; confidence interval; CPB; cardiopulmonary bypass; FVIII; factor VIII; ICU; intensive care unit; LOS; length of stay; PAI-1; plasminogen activator inhibitor; PC; protein C; PPP; platelet poor plasma; PS; protein S; RFU; rel
Influence of cigarette smoking on synthesis of eicosanoids, isoprostanes and lipoxygenase metabolites in apical periodontitis
Keywords: پلاکت پلاسمای ضعیف; AA; arachidonic acid; AP; apical periodontitis; ASA; acetylsalicylic acid; 14C-AA; 14C labelled arachidonic acid; COX; cyclooxygenase; CS; current smoker; FS; former smoker; IPs; isoprostanes; LOX; lipoxygenase; NS; non-smoker; PG; prostaglandin; PPP; pla
The Hag-protease-II is a fibrin(ogen)ase from Hippasa agelenoides spider venom gland extract: Purification, characterization and its role in hemostasis
Keywords: پلاکت پلاسمای ضعیف; Hippasa agelenoides; Spider venom; Hag-protease-II; serine protease; Fibrino(geno)lytic enzyme; Platelet aggregation; PMSF; phenyl methyl sulphonyl fluoride; EDTA; Ethylene diamine tetra acetic acid; IAA; Iodoaceticacid; PC; Phosphatidyl choline; PS; Phos
Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats
Keywords: پلاکت پلاسمای ضعیف; FXa; factor Xa; TEG; thromboelastographic/thromboelastograph; ADP; adenosine diphosphate; PT; prothrombin time; APTT; activated partial thromboplastin time; TTO; time to occlusive thrombus formation; PRP; platelet rich plasma; PPP; platelet poor plasma; T
The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting
Keywords: پلاکت پلاسمای ضعیف; ADP; adenosine diphosphate; GP; glycoprotein; IR; intermediate responsiveness; NR; nonresponsiveness; post-PA; post-treatment platelet aggregation; PPP; platelet poor plasma; ÎA; absolute change in platelet aggregation;
Inherited bleeding disorder due to familial type 2 platelet cyclo-oxygenase deficiency
Keywords: پلاکت پلاسمای ضعیف; AA; acid arachidonic; ACD; acid-citrate-dextrose; ADP; adenosine 5â²-diphosphate; COX; cyclo-oxygenase; ETP; endogenous thrombin potential; 12-HETE; 12-Hydroxy-5,8,11,14-eicosatetraenoic acid; 12-HHTrE; 12-Hydroxy-5,8,10-heptadecatrienoic acid; PG; pro
Coagulation Inhibitor Potential: a study of assay variables
Keywords: پلاکت پلاسمای ضعیف; ABS; absorbance; APC; activated protein C; AT; antithrombin; AUC; area under the curve; CAT; calibrated automated thrombogram; CIP; coagulation inhibitor potential; DVT; deep venous thrombosis; ETP; endogenous thrombin potential; FV; Leiden, factor V R506